IMPAX CV OUTBOUND (RESULTS MANAGEMENT 2.08) IMPAX CV 2.08

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2014-10-27 for IMPAX CV OUTBOUND (RESULTS MANAGEMENT 2.08) IMPAX CV 2.08 manufactured by Agfa Healthcare Corp.

Event Text Entries

[21937485] Agfa submitted mdr report #1225058-2010-00001 to the fda on june 7, 2010 for a site in the us. A 12th occurrence is being reported for the same issue/same device: impax cv results management administration tool (rmat). This is an internal discovery determined during the implementation of the associated problem correction plan, rmat verification, as reported in fda z-2112-10. Within this 12th occurrence are 2,828 different study dates from years 2005 to october 2014, in which an individual mdr report will be submitted for each associated study date and medical record number (mrn). Currently, 10,266 reports contain this incorrect finding information.
Patient Sequence No: 1, Text Type: D, B5


[22218785] An agfa clinical analyst performed a retro-analysis and reported the findings to agfa service and agfa product quality manager. Agfa's investigation into this occurrence of rmat customization has revealed that this specific change had the potential to introduce clinical inaccuracies in patient reports. Specifically: echo r. 1. 1. 1 - incorrect measurement sentence import: the sentence "the aortic valve area, by peak velocities is calculated at ( ) cm2. " generates a measurement from aortic valve cross sectional area, not peak velocity. The potential impact of this incorrect measurement sentence is: incorrect aortic valve area method will be displayed in the sentence with a potential of under or over estimating the aortic valve area by peak velocity. Or the value may not be presented in a sentence, which creates the potential for misdiagnosis of disease status. A reportable correction is underway for this issue and has been reported to the fda via reference #z-2112-10. Agfa will follow the rmat post market verification work instructions to correct the sentence finding. Any further investigation for the site described in this report will be documented in the ongoing cfr part 806 reporting. The specific study date and medical records number/s for this mdr are: mrn: (b)(6); study date: (b)(6) 2009.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1225058-2014-01314
MDR Report Key4456211
Report Source07
Date Received2014-10-27
Date of Report2014-10-29
Date of Event2014-10-03
Date Mfgr Received2014-10-03
Device Manufacturer Date2002-03-01
Date Added to Maude2015-02-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMRS. DEBORAH HUFF
Manufacturer Street10 SOUTH ACADEMY ST
Manufacturer CityGREENVILLE SC 29601
Manufacturer CountryUS
Manufacturer Postal29601
Manufacturer Phone8644211754
Single Use0
Remedial ActionOT
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMPAX CV OUTBOUND (RESULTS MANAGEMENT 2.08)
Generic NamePICTURE ARCHIVING AND COMMUNICATION
Product CodeLLX
Date Received2014-10-27
Model NumberIMPAX CV 2.08
Catalog NumberNA
Lot NumberNA
ID NumberNA
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerAGFA HEALTHCARE CORP
Manufacturer Address1 CROSSWIND RD. MISQUAMICUT RI 02891 US 02891


Patients

Patient NumberTreatmentOutcomeDate
10 2014-10-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.